Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 1 of 19 PAGEID #: 100272 1 1 2 3 4 5 6 7 8 9 10 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF OHIO EASTERN DIVISION IN RE: E. I. du PONT de NEMOURS AND . CASE NO. 2:13-md-2433 COMPANY C-8 PERSONAL LITIGATION . . COLUMBUS, OHIO . JULY 20, 2016 . 1:30 P.M. . . . . . . . . . . . . . . . . . . . . TRANSCRIPT OF THE PROCEEDINGS OF THE TELEPHONIC STATUS CONFERENCE BEFORE THE HONORABLE EDMUND A. SARGUS, JR., UNITED STATES DISTRICT CHIEF JUDGE. APPEARANCES FOR THE PLAINTIFFS: 11 MICHAEL A. LONDON, ESQ.; ROBERT A. BILOTT, ESQ.; JON C. CONLIN, ESQ.; DAVID J. BUTLER, ESQ. 12 FOR THE DEFENDANT E. I. du PONT de NEMOURS AND COMPANY: 13 JOHN BURLINGAME, ESQ.; C. CRAIG WOODS, ESQ. 14 - - - 15 16 17 18 19 20 21 22 23 24 25 LAURA L. SAMUELS, OFFICIAL FEDERAL COURT REPORTER (614) 719-3245 Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 2 of 19 PAGEID #: 100273 2 1 Wednesday Afternoon Session 2 July 20, 2016 3 - 4 THE COURT: - - - - Good afternoon to all of you. I thought all 5 of you were pretty sick of me now, yet you still want to do 6 another phone call. 7 MR. BUTLER: 8 THE COURT: 9 Not at all, judge. Yeah, yeah. We're on the record. You have to say that. 10 MR. BUTLER: 11 THE COURT: Sorry about that. But I understand that -- The plaintiffs asked 12 for this call to do with the issue of some discovery regarding 13 the, I think not yet completed but maybe about to be completed, 14 motion. 15 So who would like to speak? MR. BUTLER: Your Honor, this is David Butler. I can 16 start things off. 17 call-in number -- He misplaced it -- so he might be chiming in 18 here at any moment, but I can go ahead and kick things off. 19 And then Mike London, I just sent him the Just by way of background, this kind of whole wave of the 20 motion to compel started when in December of -- Oh, there he is. 21 Okay. 22 MR. LONDON: Sorry, sorry. 23 MR. BUTLER: That's okay. 24 THE COURT: 25 MR. BUTLER: We're good. Go ahead. Your Honor, this wave started back in Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 3 of 19 PAGEID #: 100274 3 1 December of 2015 when both Dow and DuPont announced their intent 2 to merge with each other and then do -- they announced then intent 3 then to subsequently, after the merger, to spin off into three new 4 separate, independent companies. 5 When -- After that announcement in December, the 6 plaintiffs already had a pending motion to compel related to 7 Chemours, the Chemours spinoff, and so we supplemented that motion 8 to compel in January of 2016. 9 Basically, in a nutshell, paragraph 10 of that January 10 supplement what we asked for was the schedules that were attached 11 to the merger -- or the spinoff agreement between DuPont and 12 Chemours that we had been asking for for some time. 13 for DuPont -- the DuPont-Dow merger documents that would show 14 where the liabilities were going to go after the merger and the 15 subsequent three-way split. 16 discovery on the merger and three-way split once we got that 17 information. 18 We also asked We also asked for additional limited This issue came up at the next status conference, which 19 was on March 23 of 2016. 20 -- The Court asked DuPont's counsel to take a look at this and see 21 what information was available and then basically report back to 22 everyone at the next status conference. 23 As reflected in PTO 44, what the Court In the meantime, what DuPont produced was a new 24 declaration of Julie Mazza, who is an in-house attorney with 25 DuPont, to kind of take the place of the prior declarations that Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 4 of 19 PAGEID #: 100275 4 1 had been supplied by an in-house attorney that was no longer with 2 DuPont. 3 In April then of 2016, we supplemented our motion to 4 compel. 5 basically in our view just parroted some public information that 6 was on the file with the SEC, was not responsive and did not allay 7 our concerns about where -- what was going on with both the 8 schedules from the DuPont-Chemours and what was going to go on 9 with the merger. 10 Plaintiffs believe that the Mazza declaration, which Specifically, on page 2 of that third supplement, we 11 incorporated the prior paragraph 10 what we had asked for in 12 January, asking for documents related to the Dow-DuPont merger and 13 then additional limited discovery on the merger and the three-way 14 split. 15 As the Court will recall, this came to a head somewhat 16 during the Freeman trial on about day 4 or 5; and on -- during the 17 June 3 morning conference in response to some press reports in the 18 financial press, this issue kind of came to a head; and Your Honor 19 verbally stated that you would be ordering that the items in that 20 April 2 supplement, which had incorporated paragraph 10 of the 21 January motion, would be ordered to be produced, which included 22 the Chemours-Dow-DuPont merger documents and the schedules. 23 This issue also came up on a Sunday telephone conference 24 call where the Court again reiterated what would be produced. And 25 then in that discussion, basically everyone decided we would just Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 5 of 19 PAGEID #: 100276 5 1 go ahead and self execute the Court's prior verbal order rather 2 than have the Court put something on the docket ordering the 3 productions. 4 So that brings us to kind of where we are. Since that 5 telephone call and the Court's verbal order, the only things that 6 have been produced by DuPont in response is a Form S-4 that was on 7 file, which is a public-filing document related to the announced 8 plans that was filed with the SEC, there was also a new 9 declaration from, again, from Julie Mazza which authenticated a 10 public proxy statement that has also been filed with the SEC. 11 then in that declaration, Ms. Mazza further sort of just 12 summarizes what is contained within the proxy statement. 13 all that DuPont has given us. And That's 14 What we do not have is we do not have the schedules from 15 the Chemours-DuPont spinoff that we have been asking for and what 16 we believe the Court ordered. 17 underlying Dow-DuPont merger documents that have been properly 18 authenticated by a DuPont person. 19 additional discovery that we would like on this issue, and we have 20 been told basically that we're not going to get anything else. 21 We also do not have any of the We have also provided a list of And in the meantime -- and Mike London can speak more to 22 this -- but in the meantime, the Court will recall during the 23 conference when the Court gave the verbal order, the Court 24 mentioned that there would only be one attorney, who could review 25 the information, and also a CPA. Mr. London endeavored to go out Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 6 of 19 PAGEID #: 100277 6 1 and retain a securities attorney to have the right -- someone who 2 had the right, you know, background and knowledge to review 3 intelligently that information once we got it. 4 We do have somebody engaged now in that regard. 5 folks have looked at what was given to us, this S-4 and the proxy 6 statement, and we have -- you know, they have confirmed with us 7 that the schedules that have not been provided in the merger 8 documents are what we really need to verify what is going on with 9 this liability. 10 Those And, obviously, the concern is that if these stated 11 plans, the simultaneous shareholder meetings for both Dow and 12 DuPont to vote on this merger are today, and the announced plans 13 then would be to spin off within a period of time to three 14 separate entities that basically are, if everything goes as 15 announced, DuPont would some day no longer exist within the 16 foreseeable, you know -- 17 THE COURT: Before I hear from the plaintiffs, let me ask 18 you a simple question. 19 already public information? 20 21 MR. BUTLER: Have you received anything that was not Your Honor, the only thing we received that was not public was this additional Julie Mazza declaration -- 22 THE COURT: 23 or how not detailed is that? 24 MR. BUTLER: 25 How -- I don't -- Explain that. How detailed It's not detailed, in our opinion, at all. It basically -- What it does is summarizes the proxy statement. Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 7 of 19 PAGEID #: 100278 7 1 It authenticates the proxy statement and says, here's a true and 2 accurate copy of the proxy statement, and then proceeds to 3 summarize what that says. 4 THE COURT: 5 MR. BUTLER: 6 THE COURT: 7 MR. BUTLER: 8 THE COURT: 9 Is the proxy statement -And -Is the proxy statement a public document? Yes, it is. So it's summarizing a public document? All right. 10 Let me hear from the defendant. 11 MR. BURLINGAME: Sure, Your Honor. This is John 12 Burlingame. 13 transcript from, I think it was, a Sunday afternoon telephone call 14 that the Court had, and the Court was very explicit and everybody 15 agreed that there didn't need to be an order. 16 Your Honor, I'm looking at the June 5, 2016, And you said, and I'm quoting from page 25: Just to be 17 clear, it was pretty simple, I took the plaintiffs' second 18 supplement, and that's docket no. 4516 -- and on the second page 19 there are two categories of information requested numbered one and 20 two, and that's what I ordered. 21 Number one said, a copy of any existing documentation, 22 paren, authenticated by a current DuPont declaration, closed 23 paren, to clarify where the liabilities and obligations of DuPont 24 will fall if the proposed Dow-DuPont merger and subsequent 25 three-way split occurs. Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 8 of 19 PAGEID #: 100279 8 1 After that, DuPont issued the proxy statement that is 2 very voluminous and, yes, it is a public document, and we, about a 3 month ago, provided a declaration that the Court doesn't have, but 4 I'll read pertinent portions of it, as described in the proxy 5 statement in connection with the proposed merger transaction. 6 Dow and DuPont will each merge with separate wholly-owned 7 subsidiaries of DowDuPont, with Dow and DuPont being the surviving 8 entities in such mergers and, as a result, becoming subsidiaries 9 of DowDuPont. 10 From paragraph 6, upon the consummation of the merger 11 transaction, the alleged liabilities and obligations associated 12 with the litigation will remain with DuPont, and there is no 13 expectation or plan that DuPont will be liquidated or otherwise 14 merged out of existence through the proposed merger transaction. 15 Paragraph 7, Dow and DuPont currently intend that 16 following the consummation of the proposed merger, DowDuPont will 17 pursue in all cases, subject to the receipt of approval by the 18 post-merger DowDuPont board and constituent advisory committee as 19 well as any required regulatory approvals, the separation of 20 DowDuPont into three independent, publicly-traded companies, the 21 so-called spinoff transactions, consisting of the combined 22 agriculture, material and science and specialty products. 23 It goes on -- I'll start paraphrasing to just to try to 24 truncate this, Your Honor -- but the merger transaction is not 25 conditioned on the termination -- on the determination to proceed Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 9 of 19 PAGEID #: 100280 9 1 with the spinoff transactions, and such determination whether to 2 proceed with any or all proposed spinoff transactions will only be 3 made after consumption -- after consummation of the proposed 4 merger. 5 The post-merger DowDuPont board may at any time prior to 6 the consummation of any of their proposed spinoff transactions 7 determine to abandon any or all such transaction, and no assurance 8 can be or have been given to any such transactions will occur. 9 Now in short, Your Honor, it is contemplated that there 10 will be spinoff transactions for three separate, publicly-traded 11 companies. 12 those that will be making recommendations to the board of 13 DowDuPont with respect to allegations of allocation of assets and 14 liabilities. 15 There will be advisory boards constituted for each of There has been no determination whatsoever in terms of 16 where the liabilities that currently are held by DuPont will go if 17 they ultimately go into any of the three contemplated spinoff 18 transactions. 19 THE COURT: Well, let me -- I don't have the document in 20 front of me, and there's no reason I should, so that's not a 21 criticism, but it's kind of hard to absorb this without having it. 22 MR. BURLINGAME: 23 THE COURT: Sure. But let me go back. You referenced a 24 transcript from June 5, all accurate, but I have also a transcript 25 from June 3 where when I ordered this, I made it clear that there Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 10 of 19 PAGEID #: 100281 10 1 will be an eyes-only set of people to look at this on the 2 plaintiffs' side, clearly not contemplating that we were only 3 looking at public records. 4 So I start with the idea that I assumed -- and no one 5 contradicted me at the time -- that this was going to be something 6 that was confidential, something that was more detailed than 7 general statements about, well, we'll look at this after the 8 merger and something, frankly, a little more fine tuned as far as 9 accounting aspects. 10 11 12 It sounds as though what you have sent is something purely public and, truthfully, purely general. MR. BUTLER: Your Honor, on June 3 also you were very 13 specific that you would -- you included a statement about the 14 schedules -- 15 THE COURT: Yes. 16 MR. BUTLER: 17 THE COURT: The exact quote is -- 18 MR. BUTLER: -- on the mergers. 19 THE COURT: 20 MR. BUTLER: -- being ordered to be produced -- Right. Also the specific reference to document 21 4516, which is the second supplement to the third motion to 22 compel, there's two items there. 23 there is a copy of the documentation. 24 with all due respect, we don't have to take Ms. Mazza's word for 25 what -- We wanted to see the underlying documents that were And what we -- What it asks for We don't have -- I mean Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 11 of 19 PAGEID #: 100282 11 1 authenticated by a declaration, not a declaration describing what 2 supposedly the underlying documents say. 3 And then also we can't lose sight that this was all 4 buttressed on the January motion to compel, which is incorporated 5 into what the Court cited, which is, you know, talks about the 6 Chemours spinoff schedules, which we still want, which, again -- 7 THE COURT: One thing I want to be clear on. 8 request, I didn't reduce this to an order. 9 transcript. 10 At DuPont's That's clear in the I'm sure everybody agrees with that. But it was also clear that in the plaintiffs' third 11 motion supplement, I adopted two paragraphs with the addition just 12 mentioned, which includes as well as Chemours schedules in part 13 one. 14 I don't think a proxy statement comes anywhere close to 15 that when the proxy statement just says, we'll look at it in the 16 future. 17 something, Mr. Burlingame, you can tell me. 18 that there aren't schedules, documents, indicating there was due 19 diligence performed, all this occurred, and there had to be 20 something in writing to document it, and I don't hear any of this 21 being disclosed. 22 That's pretty much what I heard. MR. BURLINGAME: If I'm missing But I can't believe Your Honor, I'm going back to paragraph 23 one, on the second page of the supplement, which you 24 unquestionably ordered, and it talks about clarifying where the 25 liabilities and obligations of DuPont will fall if the merger goes Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 12 of 19 PAGEID #: 100283 12 1 forward. 2 And I can't produce what isn't out there. The -- There 3 are no documents, and Ms. Mazza in her declaration attested to 4 that fact. 5 more detail, beyond the proxy statement, where the liabilities and 6 obligations of DuPont, including the alleged liabilities and 7 obligations for the litigation, will fall if the proposed merger 8 and three-way split occurs. 9 THE COURT: DuPont does not have any documents that address in any Well -- 10 MR. BILOTT: 11 THE COURT: 12 You know, I'm not questioning you, Mr. Burlingame, 13 personally. Your Honor, this is Rob Bilott. Wait, wait, wait. I have the floor. Don't take it that way. 14 MR. BURLINGAME: 15 THE COURT: I don't, judge. But this is -- look. DuPont and Dow didn't 16 just blindly merge or attempt to merge. There had to be details, 17 due diligence, documents, listings, all these sorts of things. 18 And when there is a proposal that the shareholders already know 19 about, it's public, indicating there's going to be a three-way 20 split, obviously there is some planning for that. 21 happen in a day. 22 for the public documentation, you know, we're not the SEC here. 23 We are not trading on this information. 24 public. 25 CPA selected, who would have to sign a document, verifying he or That can't That's what I anticipate this to be. Waiting And I assumed it wasn't That's why we put this whole procedure in place to have a Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 13 of 19 PAGEID #: 100284 13 1 she knew the confidentiality of the documents, wouldn't disclose 2 them to anyone else. 3 were dealing with proxy statements and matters made public through 4 the SEC filings. 5 There would be no reason to do that if you That just wouldn't make sense. MR. BURLINGAME: It was: Your Honor, again, I go back to the 6 order. What happens to the liabilities? And I'm 7 certain, as you are, judge, that there was valuation of potential 8 liabilities on -- all over this transaction. 9 question, what happens to those liabilities, is something that But that the core 10 hasn't been addressed and won't be addressed until these advisory 11 boards are constituted and make recommendations to the DowDuPont 12 board. 13 THE COURT: Right. 14 MR. BURLINGAME: 15 THE COURT: So the whole time -- But there is a difference -- There's a 16 difference between deciding and analyzing. And I can understand 17 that maybe it takes final board actions, and the boards haven't 18 been really constituted. 19 of this somewhere along the way, and that would be existing 20 documentation, in my view, at least oral order in this case. 21 mean I have to assume -- I understand that board action hasn't 22 been taken on this. 23 is. 24 seems to me to be subsumed in the first paragraph of what I 25 ordered. But there has to have been some analysis I You can't tell anybody what the board action But there have been steps taken and analyses made, and that Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 14 of 19 PAGEID #: 100285 14 1 MR. WOODS: Your Honor, this is Craig Woods. I think, at 2 least what we're being told is, there has not been an analysis of 3 this specific question of where the liabilities are likely to go 4 in the event of a three-way split. 5 THE COURT: Well, I'll tell -- You know, I am -- Again, 6 this has nothing to do with anybody on the phone call -- I'm 7 feeling a bit frustrated. 8 very quickly schedule a hearing and have a principal come in who 9 is involved in this. I think the only option I can see is to If it's going to be things that aren't 10 public, we will make it all under seal, and we will do that, and 11 the lawyers will be bound by confidentiality. 12 takes and the more difficult it becomes to get this information, 13 truthfully, the more I'm determined that there is something that 14 needs to be ferreted out here. 15 nothing. 16 more things aren't disclosed, the more suspicious everybody 17 becomes, and I think that's the situation we're in right now. 18 But the longer this I hope it turns out to be the big But I can tell you from long experience in this job, the So I'm going to ask you to consult about schedule, and 19 then I am going to order a very high-level person, someone who is 20 intimately familiar and was at the table in making this deal and 21 is at the table in guiding how the new corporation will be formed, 22 has to come in and give testimony and bring in any related 23 documentation with them. 24 MR. BURLINGAME: 25 Burlingame. Your Honor, may I make a -- This is John May I make a suggestion, judge? Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 15 of 19 PAGEID #: 100286 15 1 THE COURT: I'll listen. 2 MR. BURLINGAME: Thank you. This is the first that I 3 have heard -- I know that plaintiffs' counsel has been trying to 4 line up a CPA type. 5 have somebody lined up. 6 touch with us, provide the specifics of whatever it is that he or 7 she thinks is out there provided under this protective order. 8 will get to it promptly and then determine whether that 9 satisfactorily addresses the issue with the PSC. 10 THE COURT: This is the first that I have heard that they I would suggest that that person get in We I think -- As long as we can do that quickly, 11 and I'm sure you are prepared to do that, I think that might be 12 the course to go. 13 I'm -- How many days do you think this would take? 14 MR. LONDON: 15 THE COURT: Your Honor -Well, just to be clear, I'm thinking a very 16 short period of time here. 17 doesn't work, you will notify me, and then we will do what I just 18 suggested. 19 MR. LONDON: I'm not -- and, you know, if that Your Honor, Michael London here. And we 20 have been consulting with this law firm who was retained over a 21 month ago. 22 telling us, frankly, just as Your Honor said, and we have lost 23 sight of this, that the schedules for the Chemours spinoff exist. 24 They exist. 25 with a spinoff requires the schedules to be filed with the spinoff And they have been guiding us in these requests and They unequivocally exist. And many times the SEC Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 16 of 19 PAGEID #: 100287 16 1 agreement. 2 filed. 3 critical, and they exist. 4 Sometimes the SEC does not require the schedules to be But the schedules of the Chemours spinoff are absolutely THE COURT: This is -- I -- You know, I don't want to cut 5 you off, but what I want to say is this. 6 been direct communication between your retained expert, or 7 whatever you want to call them, professional, and anybody from 8 DuPont. 9 10 I want -- There hasn't Is that correct? MR. BURLINGAME: That's correct, judge. This is John Burlingame. 11 THE COURT: So let's just -- wait. What I'm talking 12 about is a very short period of time, days, not weeks, days. 13 want that to happen, and I want to see if is some opportunity 14 still to get the information. 15 hearing in about ten days or less. 16 MR. BILOTT: I If not, then I'm thinking of a Your Honor, this is Rob Bilott. I think one 17 thing that does need to be made clear is this is really another 18 delay by DuPont. 19 information we need, and we have been asked to give it to our new 20 consultants here. 21 nothing new we're going to be asking them for. 22 what they need. 23 point. 24 25 We have already conveyed to DuPont what We have already conveyed that. There is They already know They're just refusing to turn it over at this MR. LONDON: Judge, if I can -- This is Michael London -- the schedule is the first thing that they are going to tell John Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 17 of 19 PAGEID #: 100288 17 1 Burlingame that they need, and John has not sent a schedule. 2 We're happy to have orders to meet and confer with them. 3 THE COURT: I want everybody to relax for a second. I'm 4 looking at my calendar, and I realize you're all in front of me 5 next Wednesday and Thursday. 6 hearing date on Thursday. 7 through the exercise Mr. Burlingame has suggested. I don't want 8 to be doing this if this can be still worked out. So we're going 9 to be -- come prepared -- Two things: Right? So let's talk about a But what I want you to do is still go Come prepared on Thursday 10 to argue this; and, Mr. Burlingame, you're going to need, and 11 Mr. Woods you are going to need, a principal on that date unless 12 you can work with the other side and see this problem resolved. 13 And when say a principal I mean someone who doesn't have to call 14 anybody, doesn't have to refer to anybody, who can come in here 15 with the kind of information that will tell us exactly how this 16 has been anticipated if not finalized. 17 seal. 18 Thursday. And it will be all under But we will go forward, and we will set that for 1:30 on 19 All right. And what I would like you to do is report 20 back to me maybe by Friday of this week to let me know where this 21 stands. 22 All right? MR. BURLINGAME: Judge, just to be -- just to be clear in 23 my understanding, you're talking about if this isn't resolved, 24 you're expecting a hearing at 1:30 on Thursday with this issue? 25 THE COURT: With a witness from DuPont with -- with great Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 18 of 19 PAGEID #: 100289 18 1 knowledge about anticipated actions to be taken, analyses, not 2 necessarily decisions but analyses, of assets, liabilities, where 3 they may or may not fall. 4 contemplated, and I want somebody who knows of those 5 contemplations and bring documents that would support whatever the 6 testimony is. 7 all under seal unless something else takes place. 8 9 10 At this point I'm going to assume it's going to be All right. And so you'll let Penny know on Friday where we are on this, and then I will look forward to seeing you next Wednesday. Thank all of you. 11 MR. BUTLER: 12 MR. BURLINGAME: 13 14 15 16 17 18 19 20 21 22 23 24 25 I'm sure these have all been Thank you, Your Honor. Thank you, Your Honor. - - - Case: 2:13-md-02433-EAS-EPD Doc #: 4590 Filed: 07/21/16 Page: 19 of 19 PAGEID #: 100290 19 1 C E R T I F I C A T E 2 3 - - - I, Laura L. Samuels, do hereby certify that the foregoing is 4 a true and correct transcript of the proceedings of the Telephonic 5 Status Conference in the case of: 6 Company C-8 Personal Litigation, case no. 2:13-md-2433, before the 7 Honorable Edmund A. Sargus, Jr., Chief Judge, in the United States 8 District Court, Southern District of Ohio, Eastern Division, on the 9 date indicated, reported by me in shorthand and transcribed by me or 10 E. I. du Pont de Nemours and under my supervision. 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 /s/ Laura L. Samuels Laura L. Samuels Official Federal Court Reporter